How Frelick was paid
$426,269 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Total |
|---|---|---|---|---|
| Jeffrey FrelickChief Executive Officer and President | $300,000 | $26,269 | $100,000 | $426,269 |
| Deina WalshChief Financial Officer | $200,000 | $13,136 | $50,000 | $263,136 |
What changed and why
- $426K$426,269 was CEO total compensation in 2025, compared with $384,897 in 2024.
- $100K$100,000 was the CEO’s 2025 performance-based cash award, tied to clinical development, business development, capital raising, and investor goals.
- $26,269$26,269 represented CEO 2025 option awards; no stock awards, bonus, pension, or other compensation was reported.
- $50,000$50,000 was the CFO’s 2025 performance-based cash award, while her total compensation was $263,136.
- 16,668 CEO and 8,335 CFO options were granted January 8, 2026, outside the reported 2025 compensation table.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.